[Treatment of perianal fistulas with mesenchymal stem cells]
Helene Rask Dalby1, Helene Perregaard2, Anders Dige3
1Mave- og Tarmkirurgi, Aarhus Universitetshospital.
Ugeskrift for Laeger
|April 12, 2022
Abstract:
Treatment of perianal fistulas are challenged by insufficient healing and a high rate of relapse. Existing sphincter-sparing procedures have healing rates of around 50%. Treatment with mesenchymal stem cells of both autologous and allogenic origin and freshly collected autologous adipose tissue show both promising healing rates and few complications and may be offered to patients with complicated fistulas not suited for other treatment modalities.
